BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 66859)

  • 1. The murine sarcoma virus-induced tumor: exception or general model in tumor immunology?
    Levy JP; Leclerc JC
    Adv Cancer Res; 1977; 24():1-66. PubMed ID: 66859
    [No Abstract]   [Full Text] [Related]  

  • 2. [Rejection of non viral tumors caused by infection with murine sarcoma virus].
    Basombrio MA
    Medicina (B Aires); 1977; 37(2):127-32. PubMed ID: 197370
    [No Abstract]   [Full Text] [Related]  

  • 3. Murine sarcoma virus pseudotypes used as immunogens against viral and chemical oncogenesis.
    Basombrío MA; Mayer AM; Pasqualini CD
    Cancer Res; 1977 Jun; 37(6):1768-76. PubMed ID: 192461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulatory effect of immunization on tumor induction by Moloney murine sarcoma virus.
    Murasko DM; Prehn RT
    J Natl Cancer Inst; 1978 Nov; 61(5):1323-7. PubMed ID: 213613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic and virologic studies of a nonproducer tumor induced by murine sarcoma virus (Harvey).
    McCoy JL; Ting RC; Morton DL; Law LW
    J Natl Cancer Inst; 1972 Feb; 48(2):383-91. PubMed ID: 4347035
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanisms of escape from immune surveillance.
    Klein G
    Natl Cancer Inst Monogr; 1976 Nov; 44():135-6. PubMed ID: 193018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic specificity of cell-mediated antitumor reaction in the MSV system.
    Leclerc JC; Gomard E; Levy JP; Senik A
    Bibl Haematol; 1975 Oct; (43):173-6. PubMed ID: 60997
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunological study of two stocks of Moloney sarcoma virus producing regressor and progressor tumors in C57BL/6 mice.
    Takeichi N; Boone CW; Holden HT; Herberman RB
    Int J Cancer; 1978 Jan; 21(1):78-84. PubMed ID: 203543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity of 51Cr-release cytotoxicity of lymphocytes immune to murine sarcoma virus.
    Herberman RB; Aoki T; Nunn M; Lavrin DH; Soares N; Gazdar A; Holden H; Chang KS
    J Natl Cancer Inst; 1974 Oct; 53(4):1103-11. PubMed ID: 4139276
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro interactions between tumor cells and immune lymphoid cells.
    Levy JP; Gomard E; Senik A; Leclerc JC
    Recent Results Cancer Res; 1976; (56):24-30. PubMed ID: 188084
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationships between H-2 and viral antigens in murine oncornavirus-induced tumours.
    Gomard E; Duprez V; Henin Y; Levy JP
    J Immunogenet; 1977 Feb; 4(1):35-45. PubMed ID: 192802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization to effector lymphocytes associated with immunity to murine sarcoma virus (MSV)-induced tumors. II. Repeated stimulation and proliferation in vitro of specific cytolytic T lymphocytes.
    Plata F; Jongeneel CV
    J Immunol; 1977 Aug; 119(2):623-9. PubMed ID: 196025
    [No Abstract]   [Full Text] [Related]  

  • 13. H-2 region product as determinant in immune cytolysis of syngeneic tumour cells by anti-MSV T lymphocytes.
    Gomard E; Duprez V; Henin Y; Levy JP
    Nature; 1976 Apr; 260(5553):707-9. PubMed ID: 177884
    [No Abstract]   [Full Text] [Related]  

  • 14. A non-virion surface antigen on Moloney sarcoma virus-transformed non-producer and producer cells.
    Hunsmann G; Weiland E; Mussgay M; Schneider J
    J Gen Virol; 1980 Aug; 49(2):375-84. PubMed ID: 6255072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine sarcoma virus defectiveness. Viral polymerase expression murine and nonmurine host cells transformed by S+L-type murine sarcoma virus.
    Peeples PT; Gerwin BI; Papageorge AG; Smith SG
    Virology; 1975 Oct; 67(2):344-55. PubMed ID: 52940
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent progress in studies of mouse type-C viruses.
    Sarma PS; Gazdar AF
    Curr Top Microbiol Immunol; 1974; (68):1-28. PubMed ID: 4375018
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antigenic systems of tumors and leukemias induced by oncornaviruses].
    Levy JP; Kourilsky FM
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):741-53. PubMed ID: 4340545
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection of cellular immunity to murine sarcoma virus-induced tumors by leukocyte adherence inhibition.
    Mortensen RF
    J Natl Cancer Inst; 1979 Jan; 62(1):157-63. PubMed ID: 214608
    [No Abstract]   [Full Text] [Related]  

  • 19. Abrogation of resistance to feline oncornavirus disease by immunization with killed feline leukemia virus.
    Olsen RG; Hoover EA; Schaller JP; Mathes LE; Wolff LH
    Cancer Res; 1977 Jul; 37(7 Pt 1):2082-5. PubMed ID: 67886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological responsiveness in rats infected with the Soehner-Dmochowski murine sarcoma virus (MSV-SD).
    Evans DL; Barnett JW; Dmochowski L
    Tex Rep Biol Med; 1974; 32(2):449-60. PubMed ID: 4372740
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.